Literature DB >> 19559328

Complicated monochorionic twin pregnancies: updates in fetal diagnosis and treatment.

Larry Rand1, Hanmin Lee.   

Abstract

Monochorionic (MC) twin pregnancies may develop significant complications, and twin-to-twin transfusion syndrome (TTTS) has become among the best known to obstetricians and patients alike. A significant percentage of patients referred for suspected TTTS have a different underlying pathologic condition, however, and differentiating the subcategories of MC pathophysiologic conditions may change treatment course and outcome. The key to understanding complicated MC pregnancies lies in the placental angioarchitecture and intertwin vascular communications between the fetuses.

Entities:  

Mesh:

Year:  2009        PMID: 19559328     DOI: 10.1016/j.clp.2009.03.014

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  4 in total

1.  Twin-reversed arterial perfusion sequence associated with decreased fetal cerebral vascular impedance.

Authors:  S Peyvandi; V A Feldstein; S Hirose; L Rand; M M Brook; A J Moon-Grady
Journal:  Ultrasound Obstet Gynecol       Date:  2015-04       Impact factor: 7.299

2.  Guide wire assisted catheterization and colored dye injection for vascular mapping of monochorionic twin placentas.

Authors:  Eric B Jelin; Samuel C Schecter; Kelly D Gonzales; Shinjiro Hirose; Hanmin Lee; Geoffrey A Machin; Larry Rand; Vickie A Feldstein
Journal:  J Vis Exp       Date:  2011-09-05       Impact factor: 1.355

Review 3.  Evaluation and Management of Fetal Cardiac Function and Heart Failure.

Authors:  Erik Michelfelder; Catherine Allen; Lindsay Urbinelli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-09

4.  Outcomes of Monochorionic, Diamniotic Twin Pregnancies with Prenatally Diagnosed Intertwin Weight Discordance.

Authors:  Nasim C Sobhani; Teresa N Sparks; Kristen A Gosnell; Larry Rand; Juan M Gonzalez; Vickie A Feldstein
Journal:  Am J Perinatol       Date:  2020-12-15       Impact factor: 3.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.